U.S. FDA panel votes in favor of two anti-infective drugs

U.S. FDA panel votes in favor of two anti-infective drugs

[Reuters] – A panel of advisers to the U.S. Food and Drug Administration gave favorable reviews on Monday to two new medications to treat acute bacterial skin infections. The panel voted unanimously that Cubist Pharmaceuticals Inc’s tedizolid and Durata more

View todays social media effects on CBST

View the latest stocks trending across Twitter. Click to view dashboard

See who Cubist is hiring next, click here to view

Share this post